Followers | 133 |
Posts | 6559 |
Boards Moderated | 2 |
Alias Born | 06/20/2022 |

Thursday, May 25, 2023 1:14:35 PM
The ONLY disease that kills ALL of us eventually is the GROSS IGNORANCE of the so-called "DOCTORS" who can NOT cure us, fix us, heal us, nor otherwise save us from ANY MEDICAL AFFLICTIONS!!!!!!!!!!!!!!!!! Hey, Bro, when YOU yourself go in for your likely "ANNUAL WORKUP" at your "FAMILY PHYSICIAN'S" office or hospital, he or she will first assess all of your (supposed) "RISK FACTORS". In TRUTH, however, the ONLY risk factor you Sir will ever have during your entire life is that DOCTOR himself!!!!!!!
ENOUGH said by me on that subject!!! YOU, Sir, have now been EDIFIED!!!!
Liked By
Spread the love. Be the first to like this post!
Recent ELEV News
- Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference • PR Newswire (US) • 09/05/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 11:45:12 AM
- Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021 • PR Newswire (US) • 08/16/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 11:45:22 AM
- Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 08/03/2023 11:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/03/2023 11:15:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/03/2023 11:01:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/14/2023 08:29:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/14/2023 08:26:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 12:15:30 PM
- Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer • PR Newswire (US) • 07/13/2023 12:00:00 PM
- Elevation Oncology Announces Pricing of $50 Million Public Offering • PR Newswire (US) • 06/09/2023 02:41:00 AM
- Elevation Oncology Announces Launch of Proposed Public Offering • PR Newswire (US) • 06/08/2023 08:01:00 PM
- Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 • PR Newswire (US) • 06/03/2023 01:00:00 PM
- Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 05/15/2023 11:30:00 AM
- Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 • PR Newswire (US) • 04/26/2023 08:05:00 PM
- Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept Data and Highlights a Clinical Case Study in Claudin 18.2-Expressing Cancers at AACR 2023 • PR Newswire (US) • 04/17/2023 02:15:00 PM
- Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023 • PR Newswire (US) • 03/14/2023 08:30:00 PM
- Elevation Oncology Reports Fourth Quarter and Full Year 2022 Financial Results • PR Newswire (US) • 03/09/2023 12:30:00 PM
- Elevation Oncology to Participate at Upcoming Investor Conferences • PR Newswire (US) • 03/01/2023 12:00:00 PM
- Elevation Oncology to Present at the SVB Securities Global Biopharma Conference • PR Newswire (US) • 02/08/2023 12:00:00 PM
- Elevation Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/09/2023 12:30:00 PM
- Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition • PR Newswire (US) • 01/06/2023 01:15:00 PM
- Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit • PR Newswire (US) • 11/30/2022 12:30:00 PM
- J.P. Morgan downgrades Elevation Oncology (ELEV) to a Sell • TipRanks • 11/14/2022 12:06:36 PM
Nate's Food Co. Announces Reverse Merger and Change of Control with JP Energy Group to Drive Global Expansion • NHMD • Sep 22, 2023 9:00 AM
Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • TPET • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM
Aether Global Innovations Corp. Signs Strategic Partnership MOU with STA, a cutting-edge, innovative and bespoke technology solutions provider • AETHF • Sep 19, 2023 9:11 AM